LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.01
 17.99 84.90 31 898 0.0345 -0.2562
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 37.71 27.76 1306 2877 0.4538 0.7774
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 63.99 84.90 1736 8212 0.2114 0.5802
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 85.42 27.76 199 7025 0.0283 0.2798
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 16.29 84.90 1044 766 1.3614 1.2041
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 44.52 27.76 1324 3884 0.3409 0.7197
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 17.99 84.90 1040 898 1.1569 1.0875
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 92.25 27.76 2168 6873 0.3154 0.7299
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 23.10 84.90 1027 1616 0.6354 0.7976
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 87.13 27.76 205 6987 0.0293 0.2849
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 67.41 84.90 1817 8766 0.2073 0.5808
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 87.13 27.76 1954 6987 0.2796 0.7047
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 67.41 84.90 196 8766 0.0224 0.1332
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 41.11 27.76 1283 3331 0.3851 0.7419
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 19.69 84.90 43 1239 0.0347 -0.1613
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 88.84 27.76 2075 6965 0.2979 0.7181
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 19.69 84.90 1079 1239 0.8706 0.9296
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 41.11 27.76 142 3331 0.0426 0.2666
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 23.10 84.90 51 1616 0.0316 -0.1130
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 88.84 27.76 193 6965 0.0277 0.2754
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 21.40 84.90 43 1454 0.0296 -0.1529
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 90.55 27.76 1995 6928 0.2879 0.7105
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 21.40 84.90 1093 1454 0.7514 0.8653
MN20160318_Q02
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 44.52 27.76 146 3884 0.0376 0.2622
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.01
 69.11 84.90 1859 8988 0.2068 0.5823
MN20160318_Q02
N22